(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 8.93% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.
Bruker's revenue in 2024 is $2,964,500,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2024 to be $450,094,600,682, with the lowest BRKR revenue forecast at $448,945,597,323, and the highest BRKR revenue forecast at $452,924,293,356. On average, 5 Wall Street analysts forecast BRKR's revenue for 2025 to be $482,620,509,585, with the lowest BRKR revenue forecast at $475,116,881,607, and the highest BRKR revenue forecast at $495,629,881,914.
In 2026, BRKR is forecast to generate $521,472,132,167 in revenue, with the lowest revenue forecast at $521,472,132,167 and the highest revenue forecast at $521,472,132,167.